Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04QWE
|
||||
Former ID |
DAP000348
|
||||
Drug Name |
Levallorphan
|
||||
Synonyms |
Levallofano; Levallorphane; Levallorphanum; Levalorfano; Naloxiphan; Levallofano [DCIT]; Levallorphan [INN:BAN]; Levallorphane [INN-French]; Levallorphanum [INN-Latin]; Levalorfano [INN-Spanish]; Lorfan (TN); Ro-1-7700; N-Allyl-3-hydroxymorphinan; L-N-Allyl-3-hydroxymorphinan; Levo-3-hydroxy-N-allyl morphinan; (-)-3-Hydroxy-N-allylmorphinan; 17-Allylmorphinan-3-ol; 17-prop-2-en-1-ylmorphinan-3-ol
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Antinarcotic Agents
|
||||
Company |
Hoffmann La Roche Inc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C19H25NO
|
||||
InChI |
InChI=1S/C19H25NO/c1-2-10-20-11-9-19-8-4-3-5-16(19)18(20)12-14-6-7-15(21)13-17(14)19/h2,6-7,13,16,18,21H,1,3-5,8-12H2/t16-,18+,19+/m0/s1
|
||||
InChIKey |
OZYUPQUCAUTOBP-QXAKKESOSA-N
|
||||
CAS Number |
CAS 152-02-3
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Neuronal acetylcholinereceptor subunit alpha-2 | Target Info | Antagonist | [536781] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
PANTHER Pathway | Nicotinic acetylcholine receptor signaling pathway | ||||
References | |||||
Ref 538429 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 010423. | ||||
Ref 542223 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7209). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.